Interferon, a protein produced by cells, is the only non-toxic antiviral inhibiting virus multiplication in the cell. Although the industrial-technical production of the substance is more expensive the exogenic interferon treatment (interferon which is produced in cell cultures is being administered to the organism) is preferred to the endogenous interferon therapy (by application of slightly-toxic substances the organism is stimulated to produce interferon) since with the first therapy the factor toxicity can be neglected. Clinical trials with exogenous interferon treatment of herpes virus infections of men gave encouraging results, they must however be confirmed by double blind studies. Should it come to a clinical application of interferon on a large scale, first of all methods of production must be worked out to make available sufficient exogenous interferon for treatment of patients.
干扰素是细胞产生的一种蛋白质,是唯一一种无毒的能抑制细胞内病毒繁殖的抗病毒物质。尽管该物质的工业技术生产成本更高,但外源性干扰素治疗(将细胞培养产生的干扰素注入机体)比内源性干扰素疗法(通过使用低毒性物质刺激机体产生干扰素)更受青睐,因为在第一种疗法中,毒性因素可以忽略不计。对男性疱疹病毒感染进行外源性干扰素治疗的临床试验取得了令人鼓舞的结果,但仍需双盲研究加以证实。如果要大规模临床应用干扰素,首先必须找到生产方法,以便提供足够的外源性干扰素用于治疗患者。